Dr. Anant Mandawat, MD

Dr. Mandawat practices at Emory University Hospital in Atlanta, Georgia, part of Emory University.

Dr. Mandawat's NPI, 1932461456, was assigned on June 11, 2012. Dr. Mandawat graduated from Yale University School of Medicine in 2012. Dr. Mandawat holds Georgia license 79840.

Dr. Mandawat's primary practice is Emory University Hospital, at 1364 Clifton Road, NE, Atlanta, GA 30322 in De Kalb County. The practice phone is (404) 686-8500.

Dr. Mandawat's primary practice is Emory University Hospital in Atlanta, Georgia, part of Emory University. Dr. Mandawat is also affiliated with Emory University Hospital Midtown. The medical group on file is Emory Clinic. Dmand AI also links Dr. Mandawat to 1 more ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mandawat practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Mandawat's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Mandawat's licenses on file in 2 states: Georgia and Massachusetts.

CMS data shows 489 Medicare services from Dr. Mandawat across 7 procedure codes in 2024, for 301 Medicare patients. Medicare paid $35,714 for them.

CMS counts 301 Medicare patients who saw Dr. Mandawat in 2024. The largest group is 65 to 74, with 136 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mandawat's median patient age at 70, with 60% women.

In 2024, Dr. Mandawat wrote 1,121 Medicare Part D claims for 185 patients. 84% of them were for generic drugs. CMS names the drug for 982 of them, across 19 drugs with 11 or more claims each, at $128,302 in total drug cost. In 2023, CMS named 755 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Mandawat for performance year 2024, reported through an alternative payment model (APM). Dr. Mandawat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mandawat as offering telehealth.

Dmand AI links 29 papers to Dr. Mandawat, published from 2012 to 2025. 2025 was the busiest year, with 4. The most frequent topics are Hospital Mortality, Cardiovascular Diseases and Prostatic Neoplasms. Dr. Mandawat has published most often in Am Heart J. Dr. Mandawat's most frequent co-authors are Aditya Mandawat, MD, Justine V. Cohen, DO and Brian J. Forrestal, BMBS.

CMS Open Payments shows 4 general payments to Dr. Mandawat from 1 drug or device company in 2025. Consulting fees make up the largest share, 100% of the total. Sumitomo Pharma America, Inc. paid the most, $22,007.

Dr. Mandawat graduated from Yale University School of Medicine in 2012.